Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Adani Transmission Limited - Updates

2018-07-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539254 ADANITRANS

0
Adani Transmission Limited - AGM/Book Closure

2018-07-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539254 ADANITRANS

0
Adani Transmission Limited - Updates

2018-07-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539254 ADANITRANS

0
Adani Transmission Limited - Shareholders meeting

2018-07-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539254 ADANITRANS

0
Arfin India: Emerging smallcap riding value added aluminium products wave

2018-07-13 moneycontrol
In the business-to-business (B2B) segment it is difficult to win the hearts of customers particularly when products are commoditised. Taking up this challenge, Arfin India, which is into aluminium products, has consistently evolved its product categories through innovative techniques and research to stand tall in its category. During March, the company was conferred 'India’s Best Aluminium Products Manufacturing Company of the Year 2017' by IBC Infomedia, a division of International Brand Consulting Corporation, USA.
ARFIN RICOAUTO 539151 500039 520008 500228 BHUSANSTL 532508 539254 BANCOINDIA JSWSTEEL 500470 TTST TATASTEEL TATLY JSL 500055 ADANITRANS

25
Market Live: Sensex falls 150 pts, Nifty falls below 10,700 amid trade concerns

2018-07-02 moneycontrol
Buzzing: Natco Pharma share price jumped as much as 3 percent in morning after the launch of drug that is used for the treatment of Hepatitis C, in India.
BAJAJ-AUTO 500325 ADANIENT 533096 524816 RELIANCE 539254 TCHQY 532977 512599 532755 500470 NKE NATCOPHARM RIGD 500570 TATAMOTORS RLNIY ADANITRANS ANNRY TECHM 506022 TTST TATASTEEL TATLY PRAKASH ADANIPOWER TTM

1
Adani Group to raise Rs 5,000-6,000 cr via stake sale in subsidiaries

2018-07-02 moneycontrol
The Gautam Adani-led Adani Group today said it plans to raise Rs 5,000-6,000 crore of equity through a combination of primary issuances and secondary monetisation of its stake in some of its subsidiaries.
ANNRY ADANIENT 533096 539254 ADANIPOWER 512599 ADANITRANS

1
Adani to raise Rs 6,000 cr via stake sale in units

2018-07-02 freepressjournal.in
Mumbai : The Gautam Adani-led Adani Group on Sunday said it plans to raise Rs 5,000-6,000 crore of equity through a combination of primary issuances and secondary monetisation of its stake in some of its subsidiaries.
ANNRY ADANIENT 533096 539254 ADANIPOWER 512599 ADANITRANS

0
Adani Group plans to raise up to Rs 6,000 cr via securities, stake sales

2018-07-01 moneycontrol
Adani Group today said it plans to raise up to 6,000 crore through issuance of securities and stake sales in promotor group companies.
533096 539254 ADANIPOWER ADANITRANS

0
Adani Transmission Limited - Press Release

2018-06-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
539254 ADANITRANS

0
RInfra gets MERC approval for deal with Adani Transmission

2018-06-28 livemint
New Delhi: Reliance Infrastructure (RInfra) on Thursday said the Maharashtra Electricity Regulatory Commission (MERC) has approved the 100% stake sale in its integrated Mumbai power business to Adani Transmission Ltd (ATL) for an estimated value of Rs18,800 crore.
500390 RELINFRA 532662 RELEY RIFS 539254 HTMEDIA RIFA RELFF ADANITRANS

0
MERC approves sale of RInfra#39;s Mumbai power biz to Adani Transmission

2018-06-28 moneycontrol
Reliance Infrastructure today said the Maharashtra Electricity Regulatory Commission (MERC) has approved the 100 percent stake sale in its integrated Mumbai power business to Adani Transmission Ltd (ATL) for an estimated value of Rs 18,800 crore. "Following the commission's nod, the transaction is expected to be closed in July 2018. The MERC had concluded its hearing into the matter and reserved its order on June 14, 2018," it said in a BSE filing.
500390 RELINFRA RELEY RIFS 539254 RIFA RELFF ADANITRANS

0
Steady cash flows, low risk make power transmission segment a safe bet

2018-06-24 livemint
Mumbai: With over 22,000 megawatts (MW) of installed power capacity starved of coal and natural gas supplies, power generation is no longer the hot investment target it used to be. What is taking its place—where everybody now wants a piece of the action—is last-mile delivery of power: transmission.
GKO RELEY TATAPOWER RIFS 539254 RELFF 500390 RELINFRA TPCL RIFA 522287 KALPATPOWR 500400 ADANITRANS

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...